NCBI Taxonomy: 651673
Bufotes (ncbi_taxid: 651673)
found 104 associated metabolites at genus taxonomy rank level.
Ancestor: Bufonidae
Child Taxonomies: Bufotes viridis, Bufotes surdus, Bufotes pewzowi, Bufotes baturae, Bufotes oblongus, Bufotes latastii, Bufotes zugmayeri, Bufotes balearicus, Bufotes boulengeri, Bufotes turanensis, Bufotes sitibundus, Bufotes cypriensis, unclassified Bufotes, Bufotes luristanicus, Bufotes pseudoraddei, Bufotes cf. surdus FB-2009, Bufotes cf. pewzowi FB-2009, Bufotes cf. oblongus FB-2010, Bufotes cf. oblongus MS-2006, Bufotes cf. viridis CBC-2012, Bufotes cf. sitibundus SL0355, Bufotes cf. variabilis FB-2009, Bufotes cf. boulengeri MS-2008, Bufotes cf. turanensis MS-2006, Bufotes cf. variabilis MS-2006, Bufotes cf. oblongus acc. Stoeck, Bufotes cf. luristanicus FB-2010, Bufotes oblongus x Bufotes pewzowi, Bufotes baturae x Bufotes latastii, Bufotes balearicus x Bufotes siculus, Bufotes pewzowi x Bufotes turanensis, Bufotes balearicus x Bufotes viridis, Bufotes siculus x Bufotes balearicus, Bufotes variabilis x Bufotes turanensis, Bufotes cf. oblongus acc. Stoeck x Bufotes pewzowi
Arenobufagin
Arenobufagin is a natural product found in Bufo gargarizans, Bufotes viridis, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Arenobufagin is a natural bufadienolide from toad venom; has potent antineoplastic activity against HCC HepG2 cells as well as corresponding multidrug-resistant HepG2/ADM cells. IC50 value: Target: in vitro: arenobufagin induced mitochondria-mediated apoptosis in HCC cells, with decreasing mitochondrial potential, as well as increasing Bax/Bcl-2 expression ratio, Bax translocation from cytosol to mitochondria. Arenobufagin also induced autophagy in HepG2/ADM cells. Autophagy-specific inhibitors (3-methyladenine, chloroquine and bafilomycin A1) or Beclin1 and Atg 5 small interfering RNAs (siRNAs) enhanced arenobufagin-induced apoptosis, indicating that arenobufagin-mediated autophagy may protect HepG2/ADM cells from undergoing apoptotic cell death [1]. arenobufagin inhibited vascular endothelial growth factor (VEGF)-induced viability, migration, invasion and tube formation in human umbilical vein endothelial cells (HUVECs) in vitro [2]. Arenobufagin blocked the Na+/K+ pump current in a dose-dependent manner with a half-maximal concentration of 0.29 microM and a Hill coefficient of 1.1 [3]. in vivo: arenobufagin inhibited the growth of HepG2/ADM xenograft tumors, which were associated with poly (ADP-ribose) polymerase cleavage, light chain 3-II activation and mTOR inhibition [1]. Arenobufagin also suppressed sprouting formation from VEGF-treated aortic rings in an ex vivo model [2]. Arenobufagin is a natural bufadienolide from toad venom; has potent antineoplastic activity against HCC HepG2 cells as well as corresponding multidrug-resistant HepG2/ADM cells. IC50 value: Target: in vitro: arenobufagin induced mitochondria-mediated apoptosis in HCC cells, with decreasing mitochondrial potential, as well as increasing Bax/Bcl-2 expression ratio, Bax translocation from cytosol to mitochondria. Arenobufagin also induced autophagy in HepG2/ADM cells. Autophagy-specific inhibitors (3-methyladenine, chloroquine and bafilomycin A1) or Beclin1 and Atg 5 small interfering RNAs (siRNAs) enhanced arenobufagin-induced apoptosis, indicating that arenobufagin-mediated autophagy may protect HepG2/ADM cells from undergoing apoptotic cell death [1]. arenobufagin inhibited vascular endothelial growth factor (VEGF)-induced viability, migration, invasion and tube formation in human umbilical vein endothelial cells (HUVECs) in vitro [2]. Arenobufagin blocked the Na+/K+ pump current in a dose-dependent manner with a half-maximal concentration of 0.29 microM and a Hill coefficient of 1.1 [3]. in vivo: arenobufagin inhibited the growth of HepG2/ADM xenograft tumors, which were associated with poly (ADP-ribose) polymerase cleavage, light chain 3-II activation and mTOR inhibition [1]. Arenobufagin also suppressed sprouting formation from VEGF-treated aortic rings in an ex vivo model [2].
Gamabufogenin
Gamabufogenin is a steroid lactone. It is functionally related to a bufanolide. Gamabufotalin is a natural product found in Bufotes viridis, Bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways. Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways.
Hellebrigenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
Arenobufagin
Gamabufotalin
4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-({2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexyl}oxy)-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
(2r,4s,5r,6r)-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-{[(2r,3s,4s,5s)-2,3,6-trihydroxy-4-{[(2r,3r,4s,5s,6r)-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-[(1-hydroxyethylidene)amino]hexyl]oxy}-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2r,4s,5r,6r)-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-{[(2r,3s,4s,5s)-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]-4-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexyl]oxy}-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
n-[3-({6-[({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)methyl]-4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5-hydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-1,4,5,6-tetrahydroxyhexan-2-yl]ethanimidic acid
C40H70N2O29 (1042.4064050000002)
{3-[2-(dimethylamino)ethyl]-1h-indol-5-yl}oxidanesulfonic acid
3a,5a,7-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
n-(6-{[4-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-1,4,5-trihydroxyhexan-2-yl)ethanimidic acid
(2r,4s,5r,6r)-2-{[(2r,3s,4s,5s)-4-{[(2r,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]hexyl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
2-[(8-{[9a-formyl-3a,5a-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-1-hydroxy-8-oxooctylidene)amino]-5-carbamimidamidopentanoic acid
(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a,7-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
(2r,4s,5r,6r)-2-{[(2r,3s,4s,5s)-4-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]hexyl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
C43H74N2O32 (1130.4224484000001)
(2s,4s,5r,6r)-2-{[(2r,3s,4r,5r,6r)-3-{[(2s,3r,4r,5r,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(hydroxymethyl)-6-{[(2s,3s,4s,5r)-1,4,5,6-tetrahydroxy-2-[(1-hydroxyethylidene)amino]hexan-3-yl]oxy}oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
2-[(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]hexyl)oxy]-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-[(2,3,6-trihydroxy-4-{[5-hydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5-[(1-hydroxyethylidene)amino]hexyl)oxy]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
(2s)-2-[(8-{[(1r,3as,3br,5as,7s,9as,9bs,11ar)-9a-formyl-3a,5a-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-1-hydroxy-8-oxooctylidene)amino]-5-carbamimidamidopentanoic acid
n-[(2s,3s,4s,5r)-6-{[(2r,3r,4r,5s,6r)-4-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-{[(2r,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-1,4,5-trihydroxyhexan-2-yl]ethanimidic acid
2-({4-[(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl)oxy]-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]hexyl}oxy)-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
C43H74N2O32 (1130.4224484000001)
2-{[3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-5-hydroxy-2-(hydroxymethyl)-6-({1,4,5,6-tetrahydroxy-2-[(1-hydroxyethylidene)amino]hexan-3-yl}oxy)oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
n-[(2s,3s,4s,5r)-3-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-1,4,5,6-tetrahydroxyhexan-2-yl]ethanimidic acid
C40H70N2O29 (1042.4064050000002)